Volume 9, Number 6—June 2003
Research
Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia1
Mitchell J. Schwaber*†‡
, Sharon B. Wright*†, Yehuda Carmeli*†‡, Lata Venkataraman*†, Paola C. DeGirolami*†, Aneta Gramatikova§, Trish M. Perl§, George Sakoulas*†, and Howard S. Gold*†
, Sharon B. Wright*†, Yehuda Carmeli*†‡, Lata Venkataraman*†, Paola C. DeGirolami*†, Aneta Gramatikova§, Trish M. Perl§, George Sakoulas*†, and Howard S. Gold*†
Figure 1
Figure 1. Pulsed-field gel electrophoresis of selected isolates, demonstrating predominant and secondary types. Lane 1, Staphylococcus aureus NCTC 8325, used as DNA molecular weight reference marker; lanes 2 and 3, clinical isolates of type A13; lane 4, clinical isolate of type A1; lane 5, clinical isolate of type B2; lane 6, clinical isolate of type H.
1Presented in part at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.
Page created: December 22, 2010
Page updated: May 30, 2012
Page reviewed: May 30, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.